Clinical Trial

Bupivacaine With Epinephrine Over Diaphragm in Laparoscopy

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated February 10, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Postoperative shoulder pain is often reported to be particularly bothersome after laparoscopy. The benefits of local anesthetic, such as bupivacaine, applied to subcutaneous tissue for general postoperative pain management after surgery is well established. However, there have been no studies on sprayed bupivacaine over the diaphragm to reduce shoulder pain in laparoscopic surgery. The purpose of the study is to evaluate if sprayed infra-diaphragmatic bupivacaine compared to placebo (saline) will improve postoperative shoulder pain in patients undergoing benign laparoscopic gynecologic surgery. The entire study will be conducted at Cedar Sinai Medical Center.
Trial Details
NCT Number NCT07400146
Lead Sponsor Cedars-Sinai Medical Center
Conditions Postoperative Pain, Shoulder Pain
Enrollment 100 participants
Start Date 2026-02
Primary Completion 2026-07 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-02-10